NO20060775L - Muskarine acetylkolinreseptorantagonister - Google Patents

Muskarine acetylkolinreseptorantagonister

Info

Publication number
NO20060775L
NO20060775L NO20060775A NO20060775A NO20060775L NO 20060775 L NO20060775 L NO 20060775L NO 20060775 A NO20060775 A NO 20060775A NO 20060775 A NO20060775 A NO 20060775A NO 20060775 L NO20060775 L NO 20060775L
Authority
NO
Norway
Prior art keywords
receptor antagonists
acetylcholine receptor
muscarine
muscarine acetylcholine
methods
Prior art date
Application number
NO20060775A
Other languages
English (en)
Norwegian (no)
Inventor
Kristen E Belmonte
Jakob Busch-Petersen
Dramane I Laine
Michael R Palovich
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20060775L publication Critical patent/NO20060775L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20060775A 2003-07-17 2006-02-17 Muskarine acetylkolinreseptorantagonister NO20060775L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48798103P 2003-07-17 2003-07-17
PCT/US2004/022947 WO2005009439A1 (en) 2003-07-17 2004-07-16 Muscarinic acetylcholine receptor antagonists

Publications (1)

Publication Number Publication Date
NO20060775L true NO20060775L (no) 2006-04-11

Family

ID=34102735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060775A NO20060775L (no) 2003-07-17 2006-02-17 Muskarine acetylkolinreseptorantagonister

Country Status (21)

Country Link
US (1) US20060178395A1 (pt)
EP (1) EP1648460A4 (pt)
JP (1) JP2007523877A (pt)
KR (1) KR20060063890A (pt)
CN (1) CN1822838A (pt)
AP (1) AP2006003478A0 (pt)
AR (1) AR045913A1 (pt)
AU (1) AU2004259232A1 (pt)
BR (1) BRPI0412716A (pt)
CA (1) CA2532375A1 (pt)
EA (1) EA200600267A1 (pt)
EC (1) ECSP056254A (pt)
IL (1) IL172822A0 (pt)
IS (1) IS8302A (pt)
MA (1) MA27900A1 (pt)
MX (1) MXPA06000662A (pt)
NO (1) NO20060775L (pt)
PE (1) PE20050327A1 (pt)
TW (1) TW200523261A (pt)
UY (1) UY28417A1 (pt)
WO (1) WO2005009439A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050250A1 (es) * 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
WO2005037280A1 (en) 2003-10-14 2005-04-28 Glaxo Group Limited Muscarinic acetycholine receptor antagonists
AU2004281167A1 (en) * 2003-10-17 2005-04-28 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists field of the invention
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
WO2005087236A1 (en) * 2004-03-11 2005-09-22 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
EP1725238A4 (en) * 2004-03-17 2009-04-01 Glaxo Group Ltd M 3 MUSCARINACETYLCHOLINE RECEPTOR ANTAGONISTS
JP2007529513A (ja) * 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
UY28871A1 (es) 2004-04-27 2005-11-30 Glaxo Group Ltd Antagonistas del receptor de acetilcolina muscarinico
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor
WO2006055553A2 (en) * 2004-11-15 2006-05-26 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
TWI268704B (en) * 2005-06-28 2006-12-11 Realtek Semiconductor Corp Apparatus and method for detecting vertical blanking interval
US20080234315A1 (en) * 2005-08-02 2008-09-25 Jakob Busch-Petersen M3 Muscarinic Acetylcholine Receptor Antagonists
PE20091553A1 (es) 2008-02-06 2009-10-30 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
UY31636A1 (es) 2008-02-06 2009-08-03 Farmacoforos duales-antagonistas muscarinicos de pde4
AR070562A1 (es) 2008-02-06 2010-04-21 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
WO2010094643A1 (en) 2009-02-17 2010-08-26 Glaxo Group Limited Quinoline derivatives and their uses for rhinitis and urticaria
US20150093440A1 (en) * 2010-10-15 2015-04-02 Glaxo Group Limited Aggregate nanoparticulate medicament formulations, manufacture and use thereof
CN104470503A (zh) 2012-04-13 2015-03-25 葛兰素史克知识产权开发有限公司 聚集粒子
WO2021191875A1 (en) 2020-03-26 2021-09-30 Glaxosmithkline Intellectual Property Development Limited Cathepsin inhibitors for preventing or treating viral infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800481A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800482A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US6350758B1 (en) * 1996-12-02 2002-02-26 Georgetown University Tropane derivatives and method for their synthesis
US6248752B1 (en) * 1998-02-27 2001-06-19 Charles Duane Smith Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
NZ513575A (en) * 1999-05-04 2003-07-25 Neurosearch As Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP1302458A4 (en) * 2000-07-11 2005-10-19 Banyu Pharma Co Ltd ESTERDERIVATE
CN1571787A (zh) * 2001-10-17 2005-01-26 Ucb公司 奎宁环衍生物、制备它们的方法和它们作为m2和/或m3毒蕈碱受体抑制剂的用途
ES2329586T3 (es) * 2003-11-21 2009-11-27 Theravance, Inc. Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.

Also Published As

Publication number Publication date
KR20060063890A (ko) 2006-06-12
MXPA06000662A (es) 2006-03-30
AU2004259232A1 (en) 2005-02-03
IS8302A (is) 2006-02-14
US20060178395A1 (en) 2006-08-10
WO2005009439A1 (en) 2005-02-03
CA2532375A1 (en) 2005-02-03
JP2007523877A (ja) 2007-08-23
AP2006003478A0 (en) 2006-02-28
PE20050327A1 (es) 2005-06-08
UY28417A1 (es) 2005-02-28
EP1648460A4 (en) 2009-04-01
BRPI0412716A (pt) 2006-09-26
AR045913A1 (es) 2005-11-16
EP1648460A1 (en) 2006-04-26
CN1822838A (zh) 2006-08-23
EA200600267A1 (ru) 2006-06-30
TW200523261A (en) 2005-07-16
MA27900A1 (fr) 2006-05-02
ECSP056254A (es) 2006-04-19
IL172822A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
NO20065417L (no) Muskarine acetylkolinreceptorantagonister
NO20062042L (no) Muskariniske acetylkolin reseptorantangonister
NO20060775L (no) Muskarine acetylkolinreseptorantagonister
UY28598A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
UY27927A1 (es) Antagonistas del receptor muscarínico m3 de acetilcolina
NO20060776L (no) Muskarine acetylkolinreseptorantagonister
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
NO20060777L (no) Muskarine acetylkolinreseptorantagonister
NL1032713A1 (nl) Histamine-3-receptorantagonisten.
NO20063032L (no) Nye M3 muskarinacetylkolinreceptorantagoniser
TW200600093A (en) M3 muscarinic acetylcholine receptor antagonists
BRPI0506777A (pt) antagonistas do receptor muscarìnico da acetilcolina
IS8515A (is) Ný M3 múskarínasetýlkólínviðtakamótlyf
WO2006065788A3 (en) Novel muscarinic acetylcholine receptor antagonists
UY28567A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
ATE399777T1 (de) Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptors
TW200606161A (en) Muscarinic acetylcholine receptor antagonists
DE60305026D1 (de) 3,4-dihydrochinolin-2(1h)-on verbindungen als nr2b rezeptor antagonisten
WO2007016650A3 (en) M3 muscarinic acetylcholine receptor antagonists
WO2007016639A3 (en) M3 muscarinic acetylcholine receptor antagonists
DE602006010187D1 (de) Einzelsequenzhybridisierungssonden
UY28557A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
ES1057531Y (es) Maquina herramienta trifuncional independiente.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application